Novelion Therapeutics Inc. (NVLN)


Novelion Therapeutics Inc. (NVLN)

$0.87 USD

0.01 (1.16%)

Updated Jun 14 6:55pm

Add NVLN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

NVLN Daily Price Range
NVLN 52-Week Price Range

NVLN News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All NVLN News

Novelion Therapeutics Inc. (NVLN) Company Bio


Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

NVLN Stock Chart More Charts


NVLN Price/Volume Stats

Current price $0.87
Prev. close $0.86
Day low $0.84
Day high $0.88
50-day MA $1.15
200-day MA $1.44
52-week high $4.18
52-week low $0.70
Volume 42,500
Avg. volume 259,251
Dividend yield N/A
Market Cap 16.57M

NVLN Social Stream


Loading social stream, please wait...

View Full NVLN Social Stream

NVLN Returns

1-mo -26.89%
3-mo -29.84%
6-mo -11.22%
1-year -78.14%
3-year -87.83%
5-year -96.56%
YTD 3.57%
2018 -73.08%
2017 -62.95%
2016 -36.69%
2015 -33.67%
2014 -28.01%
Page generated in 0.453 seconds.